Genscript Biotech Corp is biotech service company. The Company provides life science services and products and pre-clinical drug development services.

Next Day Disclosure Return

Announcements and Notices - [Other - Business Update]

Voluntary Announcement: Financial Results For The Third Quarter Ended 30 September 2025 Of A Listed Associate - Legend Biotech Corporation

Voluntary Announcement: Legend Will Present New Data At The American Society Of Hematology Annual Meeting

Voluntary Announcement: Legend Announces Preliminary Sales For Carvykti For The Quarter Ended 30 September 2025

Announcements and Notices - [Inside Information]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Genscript Biotech (1548 HK)

Next Day Disclosure Return

Voluntary Announcement: Financial Results For The Third Quarter Ended 30 September 2025 Of A Listed Associate - Legend Biotech Corporation

Voluntary Announcement: Legend Will Present New Data At The American Society Of Hematology Annual Meeting

Voluntary Announcement: Legend Announces Preliminary Sales For Carvykti For The Quarter Ended 30 September 2025

Inside Information Announcement - Probio Received Payments Under The License Agreement With Lanova Medicines Ltd.

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)